Endometrial cancer ultrasound: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{MD}} | {{CMG}}{{AE}}{{MD}} | ||
==Overview== | ==Overview== | ||
On transvaginal ultrasound, endometrial cancer is characterized by thickening of the endometrium and disruption of a subendometrial halo. | On transvaginal ultrasound, endometrial cancer is characterized by thickening of the [[endometrium]] and disruption of a subendometrial halo. | ||
==Transvaginal ultrasound== | ==Transvaginal ultrasound== | ||
| Line 9: | Line 9: | ||
Transvaginal ultrasound is the initial imaging investigation of choice for patients presenting with the usual symptom of a postmenopausal bleed. A thickened endometrium requires endometrial sampling. | Transvaginal ultrasound is the initial imaging investigation of choice for patients presenting with the usual symptom of a postmenopausal bleed. A thickened endometrium requires endometrial sampling. | ||
Transvaginal ultrasound | Transvaginal ultrasound | ||
* Endometrial carcinoma usually appears as thickening of the endometrium though may appear as a polypoid mass | * Endometrial carcinoma usually appears as thickening of the [[endometrium]] though may appear as a polypoid mass | ||
* premenopausal: normal endometrial thickness varies through the menstrual cycle | * premenopausal: normal endometrial thickness varies through the menstrual cycle | ||
* diagnosing abnormally thickened endometrium depends on knowing what the patient's point in the menstrual cycle | * diagnosing abnormally thickened endometrium depends on knowing what the patient's point in the [[menstrual cycle]] | ||
* postmenopausal: >5 mm is thickened (if not on Tamoxifen) | * postmenopausal: >5 mm is thickened (if not on Tamoxifen) | ||
* Sonographic features are non specific and endometrial thickening can also be due to benign proliferation, endometrial hyperplasia or polyps. | * Sonographic features are non specific and endometrial thickening can also be due to benign proliferation, endometrial hyperplasia or [[polyps]]. | ||
* Disruption of a subendometrial halo on ultrasound may be suggestive of myometrial involvement. | * Disruption of a subendometrial halo on ultrasound may be suggestive of myometrial involvement. | ||
Revision as of 21:13, 2 September 2015
|
Endometrial cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial cancer ultrasound On the Web |
|
American Roentgen Ray Society Images of Endometrial cancer ultrasound |
|
Risk calculators and risk factors for Endometrial cancer ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
On transvaginal ultrasound, endometrial cancer is characterized by thickening of the endometrium and disruption of a subendometrial halo.
Transvaginal ultrasound
General imaging guidelines[1] Transvaginal ultrasound is the initial imaging investigation of choice for patients presenting with the usual symptom of a postmenopausal bleed. A thickened endometrium requires endometrial sampling. Transvaginal ultrasound
- Endometrial carcinoma usually appears as thickening of the endometrium though may appear as a polypoid mass
- premenopausal: normal endometrial thickness varies through the menstrual cycle
- diagnosing abnormally thickened endometrium depends on knowing what the patient's point in the menstrual cycle
- postmenopausal: >5 mm is thickened (if not on Tamoxifen)
- Sonographic features are non specific and endometrial thickening can also be due to benign proliferation, endometrial hyperplasia or polyps.
- Disruption of a subendometrial halo on ultrasound may be suggestive of myometrial involvement.
References
- ↑ Amir Rezaee◉ and Dr Yuranga Weerakkody◉ et al "endometrial cancer ultrasound" Check
|url=value (help).